Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

This study is currently recruiting participants.

Study NCT00330551 Information provided by National Institute of Mental Health (NIMH)

First Received: May 26, 2006 Last Updated: October 11, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	November 2012
Estimated Primary Completion Date:	November 2012 (Final data collection date for primary outcome measure)

No publications provided by National Institute of Mental Health (NIMH)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Bartzokis G, Lu PH, Amar CP, Raven EP, Detore NR, Altshuler LL, Mintz J, Ventura J, Casaus LR, Luo JS, Subotnik KL, Nuechterlein KH. Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory. Schizophr Res. 2011 Oct;132(1):35-41. Epub 2011 Jul 20.